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There are controversies in the management of the neck in clinical T1N0 oral 
squamous cell carcinoma (OSCC). The aim of this study was to describe a consecutive 
cohort of stage 1 OSCC patients and report their HRQOL at a time closest to two 
years after primary surgery. Of 216 patients treated between 2007-2012, 195 were 
eligible for the analysis of health related quality of life (HRQoL), after excluding early 
death and regional recurrence. This was measured using the University of 
Washington Quality of Life V4 questionnaire.  
 
Overall response was 65% (126/195). The HRQoL outcomes were good. However, 
there were more clinically significant problems for patients in the SND group than 
W&W in appearance (14% Vs 1%, P=0.008) and pain (19% Vs 6%, P=0.04). Similar 
trends were seen for shoulder (14% Vs 8%), mood (16% Vs 8%) and speech (5% Vs 
1%) and for overall quality of life being less than good (30% Vs 16%).  
 
It is difficult to tease out why patients did or did not have neck dissection in a 
retrospective sample, but it is likely that those with SND could have had larger stage 
1 tumours. The findings highlight the importance of SND on HRQOL in domains such 
as appearance, pain, speech, swallowing and chewing. Previous studies in SND have 
tended to focus on accessory nerve injury and shoulder function, however this new 
data emphasises the need to include other domains in future trials comparing W&W, 
SND and sentinel lymph node biopsy.  
Introduction 
It has been appreciated for many years that neck dissection causes morbidity that 
impacts on health related quality of life (HRQoL).1 Management of the neck in T1/T2 
N0 oral squamous cell carcinoma (SCC) is controversial. Treatment options include 
wait and watch (W&W), sentinel lymph node biopsy (SLNB),2 and selective neck 
dissection (SND).3 Recent guidelines recommend surgical management of the neck 
as an option in early stage oral SCC.4 
 
Both optimal survival and HRQoL are important considerations.5 Neck dissection has 
been shown to improve survival in patients with early oral cancer.6  Patient reported 
outcomes following neck dissection have shown lower HRQoL in those undergoing 
neck dissection than those with no neck dissection7. Incrementally poorer quality of 
life is seen with selective neck dissection (SND), modified radical neck dissection 
(MRND) and radical neck dissection (RND).7 There is some evidence that shoulder 
morbidity is increased when level 2b is included in the neck dissection.8,9   
 
Patients undergoing W&W management of the neck have better HRQoL than those 
undergoing neck dissection. 7 This needs to be balanced against the risk of neck 
failure, the need for further treatment, and disease specific survival. It is likely that 
tumours with minimal depth of invasion have a low risk for cervical metastasis, 
hence might be more suitable for a W&W approach,10 however even relatively 
superficial lesions can metastasise.  A prospective randomised controlled trial 
suggested that there may not be a survival advantage with surgical treatment of the 
clinically node negative neck in tumours less than 3mm thick.6 It is currently not 
possible to stratify patients into a low risk group based on tumour thickness or by 
any other means. The decision on the optimal managing for the N0 neck and balance 
of risks will be different for each patient. Better understanding of morbidity can help 
inform patients to make this decision for themselves.  
 
Others have shown SLNB has no survival disadvantage in the T1 and T2 N0 OSCC 
group compared to SND.2,11 There is some evidence to suggest SLNB in this setting 
may be associated with better functional outcomes and HRQoL than SND but 
evidence is weak.12,13  It is possible that SLNB maintains the survival advantage of 
SND but retaining the HRQoL advantages of W&W. Neither assumption is yet 
certain. 
 
The main determinants of HRQoL in larger (T3/T4) oral SCC are the use of free flaps 
and post-operative radiotherapy 5 The impact of a neck dissection and shoulder 
dysfunction is less of a HRQol issue than dry mouth, speech, saliva or chewing.14 In 
contrast, patients with T1 and T2 OSCC seem to incur more morbidity from neck 
dissection than from surgery to the primary site.  There are very few papers that 
have sufficient patients with stage 1 oral cancer to allow adequate comparison 
between wait and watch and SND.13 Hence, the aim of this study was to describe a 




Audit approval was obtained from the Aintree University Hospital Audit Department 
and patients were identified using the Aintree head and neck oncology database. 
Consecutive patients with clinical T1 N0 OSCC treated by primary surgery with 
curative intent between January 2007 and December 2012 were included. The study 
period was immediately before the introduction of SLNB to the unit. SLNB was 
therefore not an option for these patients. Operative and pathology records were 
reviewed. Follow-up information to February 2016 was obtained from clinical notes 
and letters. Patients with disease beyond clinical stage I and those treated with 
palliative intent were excluded. It is the practice of the unit to send the University of 
Washington Quality of Life (UW-QOL) questionnaire to patients following treatment. 
The UW-QOL questionnaire completed at a time-point closest to 24 months and a 
minimum of 9 months from operation, was analysed.  
 
The UW-QOL questionnaire is well established.15 Version 4 consists of 12 single 
question domains, each having between 3 and 6 response options scaled evenly 
from 0 (worst) to 100 (best) according to response hierarchy. For this study, we used 
criteria derived from earlier work to determine the domains in which patients had a 
‘significant problem/dysfunction’.16 These criteria are based on a mix of domain 
scores and the importance of domains during the previous week. We also analysed 
the UWQOL using its two subscale composite scores ‘Physical function’ and ‘Social-
emotional function’ and a single six-point ‘overall’ QOL measure.17  Physical function 
is the simple average of the swallowing, chewing, speech, saliva, taste and 
appearance domain scores whilst social-emotional function is the simple average of 
the activity, recreation, pain, mood, anxiety and shoulder domain scores. Finally, a 
single item overall QOL scale was used. Patients were asked to consider not only 
physical & mental health, but also other factors, such as family, friends, spirituality 
or personal leisure activities important to their enjoyment of life.   
 
The aim was to describe HRQoL approximately two years after surgery in patients 
who had a neck dissection and those under wait and watch surveillance without 
regional recurrence. Comparative tests were performed in availability of UWQOL 
data by baseline characteristics, between neck dissection and wait and watch groups 
in baseline characteristics and in UW-QOL responses. The Mann-Whitney test was 
used to compare groups for age and UWQOL subscale scores. Statistical significance 
was set at the 5% level.   
 
Results 
Two hundred and sixteen patients met the inclusion criteria, 168 wait and watch and 
48 with neck dissection. Twenty-one of these were excluded from analysis of QOL 
data: regional recurrence (12 wait and watch, 1 neck dissection), death within 9 
months (7 wait and watch), and one wait and watch patient who presented with a 
synchronous laryngeal tumour treated by RT. This left 47 who had a neck dissection 
and 148 who had wait and watch surveillance. UW-QOL data at least 9 months after 
operation were available for analysis in 79% (n=37/47) of the neck dissection group 
(median 24 months, IQR 21-29 months after surgery) and in 60% (n=89/148) of the 
wait and watch group (median 22 months, IQR 19-27 months). There was a higher 
rate of UW-QOL data being available (80% 68/85 Vs 53% 58/110) for the earlier 
2007-9 cohort than for the 2010-12 cohort and also (79% 37/47 Vs 60% 89/148) for 
the neck dissection group . Otherwise there was no notable variation by gender, age 
group, site or primary tumour or treatment (results not shown).  Neck dissection 
patients with UWQOL data were 6 years younger on average than wait and watch 
patients (Table 1) and more had tumours located in the anterior two-thirds of the 
tongue (73% Vs 53%). The neck dissection group was also characterised by 11 (30%) 
having surgery involving free-flap tissue transfer and 3 (8%) being treated with 
adjuvant radiotherapy.  
 
Quality of life after about two years was worse for patients having a neck dissection 
than for patients in the wait and watch group (Table 2).  This was seen for both 
physical (P<0.001) and social-emotional (P=0.04) functioning and for overall QOL 
being rated as less than good (30% Vs 16%, P=0.09).  More clinically significant 
dysfunction was seen in patients in the neck dissection cohort (Table 3) for 
appearance (14% Vs 1%, P=0.008) and pain (19% Vs 6%, P=0.04). Similar trends were 
seen in the shoulder (14% Vs 8% P=0.34), mood (16% Vs 8% P=0.21) and speech (5% 
Vs 1% P=0.21) domains. When results were grouped into those with the best 
possible domain responses and those with lesser scores (Table 3), patients in the 
neck dissection cohort reported lower levels of HRQOL in all domains except anxiety. 
The most notable differences were in regard to appearance (P<0.001), speech 
(P<0.001), swallowing (P=0.008), chewing (P=0.02) and pain (P=0.02).  
 
When patients having had either free tissue transfer or radiotherapy were excluded 
(all from the neck dissection group), similar findings were obtained. Overall quality 
of life was worse with neck dissection (29%, 7/24) compared with watch and wait 
(16%, 14/87 as per Table 2), P=0.15. Physical function (P<0.001) and social-emotional 
(P=0.14) scores were also worse in neck dissection patients, with median (IQR)  
scores of 84 (69-95) and 83 (63-98) respectively.  More clinically significant 
dysfunction was seen in neck dissection patients (Table 3)  for appearance (P=0.03), 
with similar trends for pain (13% Vs 6%), shoulder (13% Vs 8%), mood (13% Vs 8%) 
and speech (4% Vs 1%) domains. With regard to achieving best possible domain 
responses neck dissection patients reported lower levels of HRQOL in all domains 






Relatively few studies report HRQOL outcomes for early stage oral cancer.12,18 There 
is a growing recognition of the importance of HRQoL in the decision making process 
and resources are available to aid clinicians in this regard.25 The aim of this study was 
to describe HRQOL outcomes of patients having undergone SND or W&W in T1N0 
oral SCC. The sample size is adequate and the questionnaire response rate is 
comparable to other HRQOL studies.13,18  The SND cohort was smaller which reflects 
that W&W strategy was routinely offered for smaller tumours at the time of data 
collection. From a retrospective sample it is difficult to understand why patients did 
or did not have neck dissection. This limitation is acknowledged. It is likely those 
having SND had larger stage 1 tumours. Another issue is that this study reports 
survivors who have not had neck failure. Of the 13 with neck failure, only 4 had 
HRQOL data, so this small subgroup were excluded from the analysis..   
 
Appearance change after neck dissection is multifactorial. While 83% of the wait and 
watch group rated themselves with the best possible response, only 22% of those 
with a neck dissection did so (P<0.001).  Weakness of the marginal mandibular 
branch of facial nerve causing smile asymmetry, cervical scar, tissue hollowing, 
radiotherapy, fibrosis and loss of skin mobility can all contribute. Weakness of the 
marginal mandibular branch of the facial nerve has been reported as being present 
in 18% of neck dissections but, severe injuries were rare (3%).19  Scarring after neck 
dissection may affect HRQoL. One study showed that SLNB resulted in a smaller scar, 
better skin complexion and less soft tissue deficit than END.12 All types of neck 
dissection appear to cause fibrosis causing stiffness, constriction and appearance 
change and low HRQoL scores in these domains.20 In one study neck tightness was 
severe enough to cause interference with daily activities in 37%, but reduced over 
time.21 There is currently no data on these issues after SLNB.  
 
Pain and numbness are common complaints after neck dissection. In our study 19% 
of END patients and 6% of the W&W group reported significant dysfunction (P=0.04). 
Another large study found 34% of patients had neck pain after SND verses 12% after 
surgical treatment of the primary cancer without neck dissection.7 Preservation of 
the cervical root branches has also been shown to decrease pain and improve 
HRQoL.22,23 
 
The severity of shoulder symptoms has been shown to relate to the type of surgery 
performed.9,13 Our data suggests worse HRQoL with SND than W&W, though 
differences were statistically non-significant.  Sacrificing the spinal accessory and 
cervical nerves results in more morbidity than when these nerves are spared.9,23  
SLNB has been shown to give better shoulder function than SND but worse 
functional outcomes than W&W.13 SLNB will likely avoid dissection of the spinal 
accessory and cervical nerves and its associated morbidity in most patients. Further 
research is required to assess if this translates into a clinically meaningful 
improvement in HRQoL. Despite there being measurable differences in shoulder 
outcomes between accessory nerve sparing neck dissections and the non-operated 
population, HRQoL outcomes in the surgical cohort still tend to be good.5 
 
Speech was reported as a clinically significant problem in 5% of the SND group 
cohort and 1% of the W&W cohort. Eighty percent of the W&W group and 41% of 
the END group gave the best possible response regarding speech (P<0.001). Another 
study found that 24% of SND and 11% of W&W patients reported impaired speech 6 
months after surgery.7 It is unclear in our study if the difference in speech is related 
to differences in tumour resection in the two groups. 
 
In this study, neck dissection patients were around 6 years younger on average and 
had more tumours located in the anterior two-thirds of the tongue. These 
characteristics could account for some of the differences in HRQoL between the 
groups, as could other factors not measured in this study such as depth of invasion. 
After exclusion of patients who had free tissue transfer or radiotherapy (all from the 
ND group), similar findings were obtained. The intention was not to adjust for 
baseline characteristics but to accept the clinical differences inherent within the 
groups and to describe the HRQoL outcomes that clinicians might expect their 
patients to report. Another limitation of our study is that our findings are from a 
single unit and decision between W&W or SND in stage 1 oral cancer might vary in 
other cancer centres.  
 
Since our data collection, evidence and guidelines have changed. SLNB is now an 
option for surgical staging. While this is a smaller undertaking than neck dissection, 
the evidence of patient reported outcome measures are yet to be determined, 13,24 
and is subject to ongoing research. Many healthcare economies will not have the 
infrastructure to provide SLNB, hence the comparison to W&W is valid. More data is 
needed to adequately inform patient decision making. Our study indicates that for 
stage 1 oral cancer we should move away from the traditional focus on accessory 
nerve injury and shoulder function and also report other aspects of HRQOL that are 
perhaps more important to patients such as appearance, pain, speech, swallowing  
and chewing. These domains should be included in future trials comparing outcomes 




1. Laverick S, Brown JS, Vaughan ED, et al. The Impact of Neck 
Dissection on Health-Related Quality of Life. Arch Otolaryngol Head 
and Neck Surgery. 2004;130:149–54.  
2. Schilling C, Stoeckli SJ, Haerle SK et al. Sentinel European Node Trial 
(SENT): 3-year results of sentinel node biopsy in oral cancer. Eur J 
Cancer. Elsevier; 2015;51(18):2777–84.  
3. Fasunla AJ, Greene BH, Timmesfield N et al. A meta-analysis of the 
randomized controlled trials on elective neck dissection versus 
therapeutic neck dissection in oral cavity cancers with clinically  node-
negative neck. Oral Oncol. 2011;47(5):320–4.  
4. Cancer of the upper aerodigestive tract assessment and management 
in people aged 16 and over. Available at; 
https://www.nice.org.uk/guidance/ng36 Last accessed 11/06/2018.  
5. Simon N. Rogers. Quality of life perspectives in patients with oral 
cancer. Oral Oncol. Elsevier Ltd; 201;46(6):445–7.  
6. D’Cruz AK, Vaish R, Kapre N et al. Elective versus Therapeutic Neck 
Dissection in Node-Negative Oral Cancer. N Eng J Med. 
2015;373(6):521-9 
 
7. Spalthoff S, Zimmerer R, Jehn P et al. Neck Dissection's Burden on the 
Patient: Functional and Psychosocial Aspects in 1,652 Patients With 
Oral Squamous Cell Carcinomas. J Oral Maxillofac Surg. 
2017;75(4):839–49.  
8. Parikh S, Tedman BM, Scott B, et al. A double blind randomised trial of 
IIb or not IIb neck dissections on electromyography, clinical 
examination, and questionnaire-based outcomes: a feasibility study. 
British Journal of Oral & Maxillofacial Surgery. British Association of 
Oral and Maxillofacial Surgeons; 2012;50(5):394–403.  
9. Gane EM, Michaleff ZA, Cottrell MA et al. Prevalence, incidence, and 
risk factors for shoulder and neck dysfunction after neck dissection: A 
systematic review. Eur J Surg Oncol. 2017;43(7):1199–218.  
10. Pentenero M, Gandolfo S, Carrozzo M. Importance of tumor thickness 
and depth of invasion in nodal involvement and prognosis of oral 
squamous cell carcinoma: a review of the literature. Head Neck. 
2005;27(12):1080–91. 
11. Yang Y, Zhou J, Wu H. Diagnostic value of sentinel lymph node biopsy 
for cT1/T2N0 tongue squamous cell carcinoma: a meta-analysis. 
European Archives of Oto-Rhino-Laryngology. 2017;274(11):3843–52.  
12. Schiefke F, Akdemir M, Weber A, et al. Function, postoperative 
morbidity, and quality of life after cervical sentinel node biopsy and after 
selective neck dissection. Head Neck. 2009;31(4):503–12.  
13. Govers TM, Schreuder WH, Klop WMC et al. Quality of life after 
different procedures for regional control in oral cancer patients: cross-
sectional survey. Clin Otolaryngol. 2016;41:228–33.  
14. Rogers SN, Laher SH, Overend L et al. Importance-rating using the 
University of Washington Quality of Life questionnaire in patients 
treated by primary surgery for oral and oro-pharyngeal cancer. Journal 
of Cranio-Maxillofacial Surgery. 2002;30(2):125–32.  
15. Rogers SN, Gwanne S, Lowe D, et al. The addition of mood and anxiety 
domains to the University of Washington quality of life scale. Head 
Neck. 2002;24(6):521–9.  
16. Rogers SN, Lowe D. Screening for dysfunction to promote 
multidisciplinary intervention by using the University of Washington 
Quality of Life Questionnaire. Archives of Otolaryngology - Head and 
Neck Surgery. 2009;135(4):369–75.  
17. Rogers SN, Lowe D, Yueh B, et al. The physical function and social-
emotional function subscales of the University of Washington Quality of 
Life Questionnaire. Archives of Otolaryngology - Head and Neck 
Surgery. American Medical Association; 2010 Apr;136(4):352–7.  
18. Boyapati RP, Shah KC, Flood V, et al. Quality of life outcome measures 
using UW-QOL questionnaire v4 in early oral cancer/squamous cell 
cancer resections of the tongue and floor of mouth with reconstruction 
solely using local methods. British Journal of Oral & Maxillofacial 
Surgery. 2013;51(6):502–7.   
19. Batstone MD, Scott B, Lowe D, et al. Marginal mandibular nerve injury 
during neck dissection and its impact on patient perception of 
appearance. Head Neck. 2009;31(5):673–8.  
20. Inoue HI, Nibu K, Saito M et al. Quality of Life After Neck Dissection. 
Arch Otolaryngol Head and Neck Surgery. 2006;132:662–6.  
21. Shah S, Har-El G, Rosenfeld RM. Short-term and long-term quality of 
life after neck dissection. Head Neck. 2001;23(11):954–61.  
22. Roh J-L, Yoon Y-H, Kim SY et al. Cervical sensory preservation during 
neck dissection. Oral Oncol. 2007;43(5):491–8.  
23. Garzaro M, Riva G, Raimondo L, Aghemo L et al. A study of neck and 
shoulder morbidity following neck dissection: The benefits of cervical 
plexus preservation. ENT-Ear, Nose Throat Journal. 2015;94(8):330–
44.  
24. Flach GB, M Verdonck-de Leeuw I, Witte BI et al. Patients' perspective 
on the impact of sentinel node biopsy in oral cancer treatment. OOOO. 
2016;122(3):279–86.  
25.  Head and Neck Database Listing Evidence on QoL. Available at; 




Table 1. Baseline clinical and demographic characteristics of 37 patients who had neck 
dissection and of 89 who were under wait and watch surveillance. All were without regional 
recurrence and had UW-QOL data available for analysis. 
 
  % with QOL 
Neck dissection 
N=37  
% with QOL 




Gender Male 54% (20) 58% (52) 0.70 
Age <55 years 35% (13) 22% (20) 
0.33  55-64 years 32% (12) 35% (31) 
 ≥65 years 32% (12) 43% (38) 
 Median (IQR) years 58 (52-66) 64 (55-69) 0.06 
Site of primary  
tumour 
%Tongue (ant 2/3) 73% (27) 53% (47)  
%Floor of mouth 14% (5) 30% (27) 0.09 
%Other 14% (5) 17% (15)  
Year of treatment 2010-2012 35% (13) 51% (45) 0.12 
Free-Flap (soft) Yes 30% (11) 0% (0) <0.001 
Adjuvant Radiotherapy Yes 8% (3) 0% (0) 0.02 
 
*Fishers exact test, apart from Mann-Whitney test for age in years 
 
Table 2. UW-QOL subscale scores and overall QOL results for 37 patients who had neck 
dissection without regional recurrence and 89 who were under wait and watch surveillance 










Physical function subscale score (0-100):  Median (IQR) 86 (70-95) 96 (87-100) <0.001 
    
Score <60 8% (3) 2% (2) 
 
60-69 16% (6) 3% (3) 
70-79 16% (6) 8% (7) 
80-89 19% (7) 15% (13) 
90-100 41% (15) 72% (63) 
Social-emotional function subscale score (0-100): Median (IQR) 83 (62-90) 91 (77-95) 0.04 
    
Score <60 22% (8) 8% (7) 
 
60-69 8% (3) 11% (10) 
70-79 16% (6) 10% (9) 
80-89 27% (10) 18% (16) 
90-100 27% (10) 53% (47) 
% rating overall QOL as being less than good  
(i.e. as very poor, poor or fair) 30% (11/37) 16% (14/87) 0.09 
*Mann-Whitney test for subscale scores and Fishers Exact test for overall QOL.  




Table 3. UW-QOL domain results for patients who had neck dissection without regional 
recurrence and for those who were under wait and watch surveillance without regional 















(score=100) P value** P value*** 
UW-QOL physical function: 
 
       
Appearance Wait and watch 89 93.8 1% (1) 16% (14) 83% (74)   
 Neck dissection 37 73.0 14% (5) 65% (24) 22% (8) 0.008 <0.001 
 Neck dissection* 24 76.0 13% (3) 58% (14) 29% (7) 0.03 <0.001 
Swallowing Wait and watch 89 94.8 1% (1) 13% (12) 85% (76)   
 Neck dissection 37 86.8 3% (1) 35% (13) 62% (23) 0.50 0.008 
 Neck dissection* 24 88.8 0% (0) 38% (9) 63% (15) >0.99 0.02 
Chewing Wait and watch 87 86.8 3% (3) 20% (17) 77% (67)   
 Neck dissection 37 75.7 3% (1) 43% (16) 54% (20) >0.99 0.02 
 Neck dissection* 24 79.2 0% (0) 42% (10) 58% (14) >0.99 0.08 
Speech Wait and watch 88 93.4 1% (1) 19% (17) 80% (70)   
 Neck dissection 37 80.0 5% (2) 54% (20) 41% (15) 0.21 <0.001 
 Neck dissection* 24 75.8 4% (1) 71% (17) 25% (6) 0.38 <0.001 
Taste Wait and watch 88 89.9 2% (2) 23% (20) 75% (66)   
 Neck dissection 36 80.3 6% (2) 39% (14) 56% (20) 0.58 0.05 
 Neck dissection* 23 83.5 4% (1) 39% (9) 57% (13) 0.51 0.12 
Saliva Wait and watch 88 90.7 4% (4) 20% (18) 75% (66)   
 Neck dissection 36 84.7 3% (1) 33% (12) 64% (23) >0.99 0.27 
 Neck dissection* 24 89.2 4% (1) 21% (5) 75% (18) >0.99 >0.99 
UW-QOL social-emotional function: 
 
    
Pain Wait and watch 88 90.1 6% (5) 22% (19) 73% (64)   
 Neck dissection 37 79.1 19% (7) 30% (11) 51% (19) 0.04 0.02 
 Neck dissection* 24 81.3 13% (3) 38% (9) 50% (12) 0.37 0.05 
Activity Wait and watch 88 83.2 8% (7) 33% (29) 59% (52)   
 Neck dissection 37 77.7 5% (2) 54% (20) 41% (15) >0.99 0.07 
 Neck dissection* 24 79.2 4% (1) 58% (14) 38% (9) >0.99 0.07 
Recreation Wait and watch 88 83.8 8% (7) 39% (34) 53% (47)   
 Neck dissection 37 77.7 5% (2) 60% (22) 35% (13) >0.99 0.08 
 Neck dissection* 24 81.3 0% (0) 63% (15) 38% (9) 0.34 0.25 
Shoulder Wait and watch 85 87.6 8% (7) 16% (14) 75% (64)   
 Neck dissection 36 77.2 14% (5) 28% (10) 58% (21) 0.34 0.08 
 Neck dissection* 24 80.8 13% (3) 25% (6) 63% (15) 0.69 0.20 
Mood Wait and watch 87 82.2 8% (7) 40% (35) 52% (45)   
 Neck dissection 37 71.6 16% (6) 51% (19) 32% (12) 0.21 0.05 
 Neck dissection* 24 74.0 13% (3) 58% (14) 29% (7) 0.45 0.07 
Anxiety Wait and watch 88 76.5 10% (9) 51% (45) 39% (34)   
 Neck dissection 37 74.3 14% (5) 46% (17) 41% (15) 0.75 0.84 
 Neck dissection* 24 80.4 8% (2) 42% (10) 50% (12) >0.99 0.36 
 
*Excluding patients having had free-flap surgery and/or radiotherapy treatment.  
**Fishers exact test comparing % with significant problem/dysfunction between the Neck Dissection and Wait 
& Watch groups 
***Fishers exact test comparing % with best possible response between the Neck Dissection and Wait & 
Watch groups 
 
